STK33-IN-1

Names

[ Name ]:
STK33-IN-1

[Synonym ]:
N-[3-Methoxy-4-(4-methyl-1-piperazinyl)phenyl]-1-(4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-6-amine
N-[3-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-1-(4-methoxyphenyl)-6-pyrazolo[3,4-d]pyrimidinamine
1H-Pyrazolo[3,4-d]pyrimidin-6-amine, N-[3-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-1-(4-methoxyphenyl)-

Biological Activity

[Description]:

STK33-IN-1 (compound 1) is a STK33 inhibitor, with an IC50 of 7 nM[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Others >> Others

[Target]

IC50: 7 nM (STK33)[1].

[In Vitro]

STK33-IN-1 (compound 1) is 2-fold selective for Aurora-B (AurB) versus STK33. STK33-IN-1 (compound 1) has proven unsuccessful in selectively killing KRAS-dependent cancer cell lines[1].

[References]

[1]. Michel Weïwer, et al. A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells. ACS Med Chem Lett. 2012 Dec 13;3(12):1034-1038.

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
613.0±65.0 °C at 760 mmHg

[ Molecular Formula ]:
C₂₄H₂₇N₇O₂

[ Molecular Weight ]:
445.52

[ Flash Point ]:
324.5±34.3 °C

[ Exact Mass ]:
445.222626

[ LogP ]:
3.12

[ Vapour Pressure ]:
0.0±1.8 mmHg at 25°C

[ Index of Refraction ]:
1.674

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.